Hardeman v. Monsanto

3:16-cv-00525 // 19-16636 // 19-16708
February 12, 2016
Final judgment
United States, Washington, DC

Edwin Hardeman
Monsanto, John Does 1-50
Aimee H. Wagstaff, David J. Wool, Kathryn M. Forgie, Jennifer A. Moore, Lori E. Andrus

Civil court
Herbicide, Glyphosate, Roundup, POEA
Compensatory damages, economic damages in the form of medical expenses, out of pocket expenses, lost earnings, punitive and/or exemplary damages for the wanton, willful, fraudulent, and reckless acts of the defendants, Pre and Post-judgment interest, plaintiff reasonable attorneys’ fees, the costs of these proceedings.
Supreme Court of Washington, DC, United States
Court of Cassation

May 14, 2021
The jury found that that Roundup’s design was defective, lacked sufficient cancer warnings and its manufacturer, agribusiness giant Monsanto, was negligent. It awarded Hardeman $5.3 million in compensation and an additional $75 million in punitive damages, later reduced to $ 25 million. This is confirmed in appeal and at the US Supreme Court.
National law

Hardeman has alleged that his use of Roundup caused him to develop non-Hodgkin lymphoma (NHL). His case is considered a “bellwether” trial for hundreds of similar cases joined in Roundup Products Liability Litigation (MDL) 3:16-md-02741-VC. The judge decided that the trial should take place in 2 phases. It will first have to be demonstrated that Roundup caused Hardeman's disease, and only if the answer is yes, it will be possible to judge whether Monsanto has acted with malice and/or withheld information. The jury, composed of 6 persons, must be unanimous for Hardeman to win his case. The hearings began on Feb. 25, and ended on March 12. After 5 days of deliberation, the jurors unanimously answered yes to the question: Did Mr. Hardeman prove by a preponderance of the evidence that his exposure to Roundup was a substantial factor in causing his non-Hodgkin's lymphoma? The 2nd phase of the trial, with the same jury, focuses on Monsanto's liability and damages and begins on 3/20/2019. On 3/27/2019, the jury awarded Hardeman more than $5 million in compensation and an additional $75 million in punitive damages. On 7/15/2019, the judge reduces the punitive damages from $75 million to $20 million to comply with the Supreme Court's constitutional standards, but dismisses Monsanto's request for a new trial for compensatory damages. On 12/13/2019, Bayer, now owner of Monsanto, lodges an appeal (Case: 19-16636) claiming that "serious errors" were made in the case and it should have never made it to trial. On 12/20/2019, the US government files an amicus brief in support of Monsanto saying that glyphosate is not a carcinogen and as a result a warning on the label was not required as California state law demands. On May 14, 2021, the US Court of Appeals for the Ninth Circuit affirmed the District Court of the Northern District of California’s judgment in favor of Edwin Hardeman in his action alleging that Monsanto’s pesticide, Roundup, caused his non-Hodgkin’s lymphoma. On August 16, 2021, Monsanto/Bayer files a petition with the U.S. Supreme Court to reverse the appeals court verdict. It presents 2 questions: 1- Whether FIFRA preempts a state-law failure to-warn claim where the warning cannot be added to a product without EPA approval and EPA has repeatedly concluded that the warning is not appropriate. 2- Whether the Ninth Circuit’s standard for admitting expert testimony is inconsistent with this Court’s precedent and Federal Rule of Evidence 702. On June 21, 2022, the U.S. Supreme Court refused to take up Monsanto's appeal of the jury's $25 million award (21-241).